tiprankstipranks
MapLight Therapeutics, Inc. (MPLT)
NASDAQ:MPLT
US Market
MPLT
MapLight Therapeutics, Inc.
RESEARCH TOOLSreports

MapLight Therapeutics, Inc. (MPLT) Income Statement

10 Followers

MapLight Therapeutics, Inc. Income Statement

Last quarter (Q4 2025), MapLight Therapeutics, Inc.'s total revenue was $0.00, a decrease of ― from the same quarter last year. In Q4, MapLight Therapeutics, Inc.'s net income was $-79.55M. See MapLight Therapeutics, Inc.’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 25Dec 24Dec 23Dec 22
Total Revenue
$ 0.00$ 0.00$ 0.00$ 0.00
Gross Profit
$ -578.00K$ -701.00K$ -556.00K$ -574.00K
Operating Expenses
$ 168.50M$ 82.25M$ 56.73M$ 30.67M
Depreciation and Amortization
$ 578.00K$ 701.00K$ 556.00K$ 574.00K
EBITDA
$ -168.50M$ -76.88M$ -55.15M$ -29.44M
Operating Income
$ -169.08M$ -82.95M$ -57.28M$ -31.25M
Other Income/Expenses
$ 7.93M$ 5.37M$ 1.57M$ 1.23M
Pretax Income
$ -161.15M$ -77.58M$ -55.71M$ -30.02M
Net Income
$ -161.15M$ -77.58M$ -55.71M$ -30.02M
Per Share Metrics
Basic EPS
$ -3.66$ -1.87$ -1.34$ -0.72
Diluted EPS
$ -3.66$ -1.87$ -1.34$ -0.72
Weighted Average Shares Outstanding
 44.02M 41.43M 41.43M 41.43M
Weighted Average Shares Outstanding (Diluted)
 44.02M 41.43M 41.43M 41.43M
Currency in USD

MapLight Therapeutics, Inc. Earnings and Revenue History